FDCA Carried Out “Absolutely Perfunctory, Premeditated And Peripheral Inquiry”: Dhanani To HC

Ahmedabad : Leader of Opposition in Gujarat Assembly, Paresh Dhanani, has termed the preliminary inquiry by the Food and Drug Control Administration (FDCA) that gave a clean chit to BJP state chief CR Paatil who distributed Covid drug from BJP office in Surat as “politically motivated and completely biased”.

In a rejoinder affidavit filed before the Gujarat High Court in connection with his petition on the “illegal distribution” of Remdesivir, Dhanani has relied on the Delhi High Court order that expressed dissatisfaction with the Drug Controller’s investigation and clean chit to BJP MP Gautam Gambhir and AAP MLAs of Delhi, who had distributed Fabiflu in Delhi during the peak of second wave of the Covid pandemic.

Navsari MP and Gujarat BJP president CR Paatil and MLA Harsh Sanghvi courted controversy in April when amid a dire shortage of the antiviral drug Remdesivir, Paatil had announced that 5,000 vials of the drug would be given free of cost to needy patients from Surat BJP office.

Contesting the clean chit given by Food and Drug Control Administration (FDCA) to Paatil and Sanghavi based on preliminary inquiry, a report of which was filed before the HC, Dhanani submitted that the FDCA has carried out “absolutely perfunctory, premeditated and peripheral inquiry inconsistent with the statutory obligation and devoid of their statutory functions and duties”.

Dhanani highlighted that his PIL raises two fundamental questions — one about two elected representatives belonging to BJP taking lead in purchasing, collecting, hoarding and distributing Remdesivir on charity from the BJP office with a political overtone and the second “abject failure on the part of Respondent 7 (FDCA)” in implementing Central government’s directives and failing to ensure that “no private individuals or association collects Remdesivir injection in large number and distributes the same in private initiative”. The matter has been posted for further hearing for August 4.

  • Related Posts

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has issued four price-related notifications dated November 2, 2026, covering the fixation…

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    During the raid, the accused were allegedly found storing medicines and pharmaceutical drugs without valid licences, permits or authorisations and replacing labels on the stored medicines. The Directorate of Enforcement…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths